alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol has been researched along with flupenthixol in 1 studies
Studies (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Trials (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Recent Studies (post-2010) (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Studies (flupenthixol) | Trials (flupenthixol) | Recent Studies (post-2010) (flupenthixol) |
---|---|---|---|---|---|
90 | 1 | 2 | 38 | 0 | 18 |
Protein | Taxonomy | alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol (IC50) | flupenthixol (IC50) |
---|---|---|---|
Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens (human) | 7 | |
Potassium channel subfamily K member 2 | Homo sapiens (human) | 2 | |
D | Rattus norvegicus (Norway rat) | 0.003 | |
D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.003 | |
D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.003 | |
D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.003 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.003 | |
WD repeat-containing protein 48 | Homo sapiens (human) | 7 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.0022 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Booth, RG; Brown, RL; Bucholtz, EC; Tropsha, A; Wyrick, SD | 1 |
1 other study(ies) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and flupenthixol
Article | Year |
---|---|
Synthesis, evaluation, and comparative molecular field analysis of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for histamine H(1) receptors.
Topics: Animals; Binding Sites; Binding, Competitive; Brain; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ligands; Models, Molecular; Pyrilamine; Radioligand Assay; Structure-Activity Relationship; Tetrahydronaphthalenes | 1999 |